Advertisement

International Journal of Hematology

, Volume 76, Issue 5, pp 446–452 | Cite as

Plasma Leptin and Leptin Receptor Expression in Childhood Acute Lymphoblastic Leukemia

  • Heike Wex
  • Edita Ponelis
  • Thomas Wex
  • Regina Dressendörfer
  • Uwe Mittler
  • Peter Vorwerk
Progress in hematology

Abstract

Recently, leptin has been shown to play a regulatory role for differentiation within the myeloid and erythroid cell lineage, whereas results of its regulatory effects on lymphocytes and related tumor cells have been contradictory. To investigate whether leptin plays a role in acute lymphoblastic leukemia (ALL), we investigated the levels of leptin in plasma with enzymelinked immunosorbent assays and the expression of the leptin receptor on malignant lymphoblasts with reverse transcriptase polymerase chain reaction (RT-PCR). At diagnosis, the leptin levels of bone marrow-derived plasma in children with ALL were found to be significantly lower than the levels of healthy control subjects (0.92 ± 0.79 ng/mL versus 3.01 ± 2.27 ng/mL, respectively). Notably, at complete hematologic remission (at day 33 of chemotherapy), leptin levels had normalized to 2.6 ± 2.4 ng/mL. To elucidate the underlying mechanism of this phenomenon, we analyzed the expression of the leptin receptor on the mononuclear cell populations of the patients. RT-PCR analysis revealed gene expression rates of 33% at diagnosis versus 71% at remission, compared with 100% for healthy control subjects. Results of immunohistochemical staining supported these findings by showing that the tumor clones themselves do not express the leptin receptor. Finally, some hypotheses that might explain the decrease of leptin levels in the presence of the tumor clone are discussed.Int J Hematol. 2002;76:446-452.

Key words

Leukemia Leptin Leptin receptor Blood cells RT-PCR ELISA 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Santos-Alvarez J, Goberna R, Sanchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes.Cell Immunol. 1999;194:6–11.CrossRefPubMedGoogle Scholar
  2. 2.
    Gainsford T, Willson TA, Metcalf D, et al. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells.Proc Natl Acad Sci U S A. 1996;93:14564–14568.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Umemoto Y, Tsuji K, Yang FC, et al. Leptin stimulates the proliferation of murine myelocytic and primitive hematopoietic progenitor cells.Blood. 1997;90:3438–3443.PubMedGoogle Scholar
  4. 4.
    Bennett BD, Solar GP, Yuan JQ,Mathias J, Thomas GR, Matthews W. A role for leptin and its cognate receptor in hematopoiesis.Curr Biol. 1996;6:1170–1180.CrossRefPubMedGoogle Scholar
  5. 5.
    Cioffi JA, Shafer AW, Zupancic TJ, et al. Novel B219/OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction.Nat Med. 1996;2:585–589.CrossRefPubMedGoogle Scholar
  6. 6.
    Nakao T, Hino M, Yamane T, Nishizawa Y, Morii H, Tatsumi N. Expression of the leptin receptor in human leukaemic blast cells.Br J Haematol. 1998;102:740–745.CrossRefPubMedGoogle Scholar
  7. 7.
    Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis.J Leukoc Biol. 2000;68:437–446.PubMedGoogle Scholar
  8. 8.
    Martin-Romero C, Santos-Alvarez J, Goberna R, Sanchez-Margalet V. Human leptin enhances activation and proliferation of human circulating T lymphocytes.Cell Immunol. 2000;199:15–24.CrossRefPubMedGoogle Scholar
  9. 9.
    Laharrague P, Truel N, Fontanilles AM, Corberand JX, Penicaud L, Casteilla L. Regulation by cytokines of leptin expression in human bone marrow adipocytes.Horm Metab Res. 2000;32:381–385.CrossRefPubMedGoogle Scholar
  10. 10.
    Wex H, Vorwerk P, Mohnike K, et al. Elevated serum levels of IGFBP-2 found in children suffering from acute leukaemia is accompanied by the occurrence of IGFBP-2 mRNA in the tumour clone.Br J Cancer. 1998;78:515–520.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Rothe G, Schmitz G. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies: Working Group on Flow Cytometry and Image Analysis.Leukemia. 1996;10: 877–895.PubMedGoogle Scholar
  12. 12.
    Gainsford T, Alexander WS. A role for leptin in hemopoieses?Mol Biotechnol. 1999;11:149–158.CrossRefPubMedGoogle Scholar
  13. 13.
    Lopez-Soriano J, Carbo N, Tessitore L, Lopez-Soriano FJ, Argiles JM. Leptin and tumor growth in rats.Int J Cancer. 1999;81:726–729.CrossRefPubMedGoogle Scholar
  14. 14.
    Tessitore L, Vizio B, Jenkins O, et al. Leptin expression in colorectal and breast cancer patients.Int J Mol Med. 2000;5:421–426.PubMedGoogle Scholar
  15. 15.
    Konopleva M, Mikhail A, Estrov Z, et al. Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities.Blood. 1999;93:1668–1676.PubMedGoogle Scholar
  16. 16.
    Gottschling-Zeller H, Birgel M, Scriba D, Blum WF, Hauner H. Depot-specific release of leptin from subcutaneous and omental adipocytes in suspension culture: effect of tumor necrosis factoralpha and transforming growth factor-beta1.Eur J Endocrinol. 1999;141:436–442.CrossRefPubMedGoogle Scholar
  17. 17.
    Fawcett RL, Waechter AS, Williams LB, et al. Tumor necrosis factor-alpha inhibits leptin production in subcutaneous and omental adipocytes from morbidly obese humans.J Clin Endocrinol Metab. 2000;85:530–535.PubMedGoogle Scholar
  18. 18.
    Kurzrock R.The role of cytokines in cancer-related fatigue.Cancer. 2001;92(suppl):1684–1688.CrossRefPubMedGoogle Scholar
  19. 19.
    Tisdale MJ. Wasting in cancer.J Nutr. 1999;129(suppl 1S): 243S-246S.CrossRefPubMedGoogle Scholar
  20. 20.
    Matthys P, Billiau A. Cytokines and cachexia.Nutrition. 1997;13: 763–770.CrossRefPubMedGoogle Scholar
  21. 21.
    Lerario DD, Ferreira SR, Miranda WL, Chacra AR. Influence of dexamethasone and weight loss on the regulation of serum leptin levels in obese individuals.Braz J Med Biol Res. 2001;34: 479–487.CrossRefPubMedGoogle Scholar
  22. 22.
    Nishiyama M, Makino S, Suemaru S, et al. Glucocorticoid effects on the diurnal rhythm of circulating leptin levels.Horm Res. 2000; 54:69–73.PubMedGoogle Scholar
  23. 23.
    Masuzaki H, Ogawa Y, Hosoda K, et al. Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing’s syndrome.J Clin Endocrinol Metab. 1997;82: 2542–2547.PubMedGoogle Scholar
  24. 24.
    Laferrere B, Fried SK, Hough K, Campbell SA, Thornton J, Pi-Sunyer FX. Synergistic effects of feeding and dexamethasone on serum leptin levels.J Clin Endocrinol Metab. 1998;83:3742–3745.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Heuck C, Wolthers OD. Serum leptin in children with asthma treated with inhaled budesonide.Respir Med. 1999;93:268–271.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2002

Authors and Affiliations

  • Heike Wex
    • 1
  • Edita Ponelis
    • 1
  • Thomas Wex
    • 2
  • Regina Dressendörfer
    • 3
  • Uwe Mittler
    • 1
  • Peter Vorwerk
    • 1
  1. 1.Otto-von-Guericke-UniversityDepartment of Paediatric Haematology and OncologyGermany
  2. 2.Clinic for GastroenterologyHepatology and Infectious DiseasesOtto-von-Guericke-UniversityMagdeburg
  3. 3.Diagnostic Systems LaboratoriesSinsheimGermany

Personalised recommendations